Precision cancer drug startup GeneCentric acquires nearby Select ImmunoGenomics
Financial terms weren’t disclosed. It’s a match that will combine informatics with immuno-therapeutics (using the body’s natural immune system to fight cancer).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed